ROYALTY PHARMA PLC's ticker is RPRX and the CUSIP is G7709Q104. A total of 324 filers reported holding ROYALTY PHARMA PLC in Q2 2023. The put-call ratio across all filers is 0.31 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $1,118,642 | +258.3% | 42,421 | +312.7% | 0.01% | +233.3% |
| Q1 2024 | $312,173 | -27.5% | 10,279 | -14.0% | 0.00% | -25.0% |
| Q1 2023 | $430,847 | -56.1% | 11,958 | -51.8% | 0.00% | -60.0% |
| Q4 2022 | $980,531 | -36.0% | 24,811 | -35.0% | 0.01% | -52.4% |
| Q3 2022 | $1,533,000 | +38.4% | 38,150 | +44.8% | 0.02% | +31.2% |
| Q2 2022 | $1,108,000 | +30.4% | 26,344 | +20.7% | 0.02% | +60.0% |
| Q1 2022 | $850,000 | +35.8% | 21,826 | +38.8% | 0.01% | +42.9% |
| Q4 2021 | $626,000 | +40.7% | 15,721 | +27.8% | 0.01% | +250.0% |
| Q3 2021 | $445,000 | – | 12,306 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SIGULER GUFF ADVISERS, LLC | 6,761,970 | $263,446,000 | 59.92% |
| Memorial Sloan Kettering Cancer Center | 1,128,255 | $43,957,000 | 50.90% |
| Vantage Consulting Group Inc | 2,727,854 | $106,277,000 | 41.47% |
| Indie Asset Partners, LLC | 756,874 | $29,488,000 | 22.15% |
| Overbrook Management Corp | 723,250 | $28,178,000 | 6.25% |
| Brown University | 621,759 | $24,224,000 | 5.93% |
| Geo Capital Gestora de Recursos Ltd | 200,692 | $8,527,000 | 3.82% |
| Lagoda Investment Management, L.P. | 141,560 | $5,515,000 | 2.97% |
| Greytown Advisors Inc. | 131,143 | $5,109,000 | 2.47% |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 2,025,610 | $78,918,000 | 2.41% |